Effect of sensing system on the incidence of myopotential oversensing during bradycardia pacing in implantable cardioverter-defibrillators

被引：12

作者：

Mann, DE ^{[1
]}

Otto, L ^{[1
]}

Kelly, PA ^{[1
]}

Reiter, MJ ^{[1
]}

机构：

[1] Univ Colorado, Hlth Sci Ctr, Div Cardiol, Dept Med, Denver, CO 80262 USA

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 2000年 / 85卷 / 11期

关键词：

D O I：

10.1016/S0002-9149(00)00776-1

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We compared the incidence of oversensing of myopotentials during bradycardia pacing in implantable cardioverter-defibrillators from 3 different manufacturers, with 3 different types of sensing systems. The Ventritex sensing system, which uses maximum gain continuously during bradycardia pacing, had a higher incidence of oversensing (24% of patients) than the sensing systems of CPI (3%) or Medtronic (0%), suggesting that the Ventritex sensing system may be unsuitable for use in a dual-chamber defibrillator.

引用

页码：1380 / +

页数：4

共 50 条

[1] Management of diaphragmatic myopotential oversensing in implantable cardioverter defibrillators
Day, J
Lauer, M
Young, C
Han, J
Goold, P
Chun, S
Liem, LB
EUROPACE 2001, 2001, : 583 - 588
[2] Incidence of oversensing resulting in inappropriate shocks in transvenous implantable cardioverter-defibrillators
Cho, YK
Corsello, A
Robotis, D
Okreglicki, A
Rosero, SZ
Daubert, JP
Huang, DT
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 89A - 89A
[3] T-Wave Oversensing with Contemporary Implantable Cardioverter-Defibrillators
Strik, Marc
Ploux, Sylvain
Eschalier, Romain
Mondoly, Pierre
Fontagne, Leslie
Ramirez, F. Daniel
Haissaguerre, Michel
Bordachar, Pierre
JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2023, 10 (10)
[4] High incidence of diaphragmatic myopotential oversensing by a specific implantable cardioverter defibrillator
Baldinger, Samuel H.
Haeberlin, Andreas
Servatius, Helge
Seiler, Jens
Noti, Fabian
Lam, Anna
Sweda, Romy
Reichlin, Tobias
Tanner, Hildegard
Roten, Laurent
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2020, 43 (02): : 234 - 239
[5] Clinical impact of ECG changes on oversensing of subcutaneous implantable cardioverter-defibrillators
Hakamata, Takahiro
Otsuki, Sou
Izumi, Daisuke
Sakaguchi, Yuta
Suzuki, Naomasa
Ikami, Yasuhiro
Hasegawa, Yuki
Yagihara, Nobue
Iijima, Kenichi
Chinushi, Masaomi
Fuse, Koichi
Inomata, Takayuki
HEART RHYTHM, 2022, 19 (10) : 1704 - 1711
[6] Single vs. dual chamber implantable cardioverter-defibrillators or programming of implantable cardioverter-defibrillators in patients without a bradycardia pacing indication: systematic review and meta-analysis
Zeitler, Emily P.
Sanders, Gillian D.
Singh, Kavisha
Greenfield, Ruth Ann
Gillis, Anne M.
Wilkoff, Bruce L.
Piccini, Jonathan P.
Al-Khatib, Sana M.
EUROPACE, 2018, 20 (10): : 1621 - 1629
[7] Causes of ventricular oversensing in implantable cardioverter-defibrillators: Implications for diagnosis of lead fracture
Gunderson, Bruce D.
Swerdlow, Charles D.
Wilcox, Jay M.
Hayman, Jean E.
Ousdigian, Kevin T.
Ellenbogen, Kenneth A.
HEART RHYTHM, 2010, 7 (05) : 626 - 633
[8] Comparison of oversensing during bradycardia pacing in two types of implantable cardioverter-defibrillator systems
Mann, DE
Damle, RS
Kelly, PA
Landers, M
Otto, L
Reiter, MJ
AMERICAN HEART JOURNAL, 1998, 136 (04) : 658 - 663
[9] Efficacy of antitachycardia pacing in hypertrophic cardiomyopathy with implantable cardioverter-defibrillators
Lee, C. H.
Kim, S.
Choi, H. O.
Kim, K. H.
Nam, G.
Choi, K.
Kim, Y.
EUROPEAN HEART JOURNAL, 2011, 32 : 921 - 921
[10] Multiple attempts of antitachycardia pacing are useful in implantable cardioverter-defibrillators
Schaumann, A
Poppinga, A
Neufert, C
Fabian, O
Herse, B
Unterberg, C
Kreuzer, H
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) : 434A - 434A

← 1 2 3 4 5 →